A randomized, double-blind, placebo-controlled study of the effect of ezetimibe on glucose metabolism in subjects with type 2 diabetes mellitus and hypercholesterolemia

por Saito, Itori, Azuma, Kyoichi, Kakikawa, Taro, Oshima, Nobuyuki, Hanson, Mary E, Tershakovec, Andrew M
Publicado 2015

Response by sex to statin plus ezetimibe or statin monotherapy: A pooled analysis of 22,231 hyperlipidemic patients

por Abramson, Beth L, Benlian, Pascale, Hanson, Mary E, Lin, Jianxin, Shah, Arvind, Tershakovec, Andrew M
Publicado 2011

Time-related trends in variability of cIMT changes in statin trials

por Davidson, Michael H., Tomassini, Joanne E., Jensen, Erin, Neff, David, Polis, Adam B., Tershakovec, Andrew M.
Publicado 2015

Effect of Switching From Statin Monotherapy to Ezetimibe/Simvastatin Combination Therapy Compared With Other Intensified Lipid‐Lowering Strategies on Lipoprotein Subclasses in Diab...

por Le, Ngoc‐Anh, Tomassini, Joanne E., Tershakovec, Andrew M., Neff, David R., Wilson, Peter W. F.
Publicado 2015

Effect of Extended-Release Niacin on New-Onset Diabetes Among Hyperlipidemic Patients Treated With Ezetimibe/Simvastatin in a Randomized Controlled Trial

por Guyton, John R., Fazio, Sergio, Adewale, Adeniyi J., Jensen, Erin, Tomassini, Joanne E., Shah, Arvind, Tershakovec, Andrew M.
Publicado 2012

Changes in Lipoprotein Particle Number With Ezetimibe/Simvastatin Coadministered With Extended‐Release Niacin in Hyperlipidemic Patients

por Le, Ngoc‐Anh, Jin, Ran, Tomassini, Joanne E., Tershakovec, Andrew M., Neff, David R., Wilson, Peter W.F.
Publicado 2013

Are post-treatment low-density lipoprotein subclass pattern analyses potentially misleading?

por Bays, Harold, Conard, Scott, Leiter, Lawrence A, Bird, Steven, Jensen, Erin, Hanson, Mary E, Shah, Arvind, Tershakovec, Andrew M
Publicado 2010

Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic cor...

por Rosen, Jeffrey B., Ballantyne, Christie M., Hsueh, Willa A., Lin, Jianxin, Shah, Arvind K., Lowe, Robert S., Tershakovec, Andrew M.
Publicado 2015

Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years

por Constance, Christian, Ben-Yehuda, Ori, Wenger, Nanette K, Zieve, Franklin, Lin, Jianxin, Hanson, Mary E, Lowe, Robert S, Tershakovec, Andrew M
Publicado 2014

Relationships Between Metabolic Syndrome and Other Baseline Factors and the Efficacy of Ezetimibe/Simvastatin and Atorvastatin in Patients With Type 2 Diabetes and Hypercholesterol...

por Goldberg, Ronald B., Guyton, John R., Mazzone, Theodore, Weinstock, Ruth S., Polis, Adam B., Tipping, Diane, Tomassini, Joanne E., Tershakovec, Andrew M.
Publicado 2010

Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US

por Marrett, Elizabeth, Zhao, Changgeng, Zhang, Ning Jackie, Zhang, Qiaoyi, Ramey, Dena R, Tomassini, Joanne E, Tershakovec, Andrew M, Neff, David R
Publicado 2014

Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy

por Foody, JoAnne M, Toth, Peter P, Tomassini, Joanne E, Sajjan, Shiva, Ramey, Dena R, Neff, David, Tershakovec, Andrew M, Hu, Henry, Tunceli, Kaan
Publicado 2013

The comparative efficacy of ezetimibe added to atorvastatin 10 mg versus uptitration to atorvastatin 40 mg in subgroups of patients aged 65 to 74 years or greater than or equal to...

por Ben-Yehuda, Ori, Wenger, Nanette K., Constance, Christian, Zieve, Franklin, Hanson, Mary E., Lin, Jian-Xin, Shah, Arvind K., Jones-Burton, Charlotte, Tershakovec, Andrew M.
Publicado 2011

Impact of Ezetimibe on New‐Onset Diabetes: A Substudy of IMPROVE‐IT

por Shah, Nishant P., McGuire, Darren K., Cannon, Christopher P., Giugliano, Robert P., Lokhnygina, Yuliya, Page, Courtney B., Tershakovec, Andrew M., Braunwald, Eugene, Blazing, Michael A.
Publicado 2023

Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long‐Term Follow‐Up After Acute Coronary Syndromes

por Fanaroff, Alexander C., Roe, Matthew T., Clare, Robert M., Lokhnygina, Yuliya, Navar, Ann Marie, Giugliano, Robert P., Wiviott, Stephen D., Tershakovec, Andrew M., Braunwald, Eugene, Blazing, Michael A.
Publicado 2017

Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo: Analysis From IMPROVE-IT

por Giugliano, Robert P., Gencer, Baris, Wiviott, Stephen D., Park, Jeong-Gun, Fuchs, Charles S., Goessling, Wolfram, Musliner, Thomas A., Tershakovec, Andrew M., Blazing, Michael A., Califf, Robert, Cannon, Christopher P., Braunwald, Eugene
Publicado 2020